Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-061004

Calithera Biosciences, Inc. · CALA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Susan Molineaux
Officer — PRESIDENT AND CEO · Director
Period of report
Jul 13, 2015
Accepted (ET)
Jul 15, 2015 · 7:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jul 13, 2015M15,282$0.48A17,782D
Common StockF1,F2Jul 13, 2015M14,330$0.48A32,112D
Common StockF1,F2Jul 13, 2015M16,396$0.96A48,508D
Common StockF1,F2Jul 13, 2015M30,279$2.64A78,787D
Common StockF2holding———117,962IBy Trust
Common Stockholding———26,875IBy Spouse

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F3$0.48Jul 13, 2015M15,282D—Dec 13, 2021Common Stock15,2824,367D
Stock Option (Right to Buy)F4$0.48Jul 13, 2015M14,330D—Jun 12, 2022Common Stock14,3309,922D
Stock Option (Right to Buy)F5$0.96Jul 13, 2015M16,396D—May 22, 2023Common Stock16,39629,009D
Stock Option (Right to Buy)F6$2.64Jul 13, 2015M30,279D—Dec 16, 2023Common Stock30,27985,434D
Stock Option (Right to Buy)F5$0.96Jul 13, 2015M14,087D—May 22, 2023Common Stock14,08724,924I
Stock Option (Right to Buy)F6$2.64Jul 13, 2015M10,288D—Dec 16, 2023Common Stock10,28823,745I

Explanation of responses